Velo3D Inc (VELO)

NASDAQInformation TechnologyIndustrial - MachinerySnapshot 2026-10-23

$6.64+2.31%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Velo3D Inc’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Measure / period	Management expectations	Analyst expectations
FY 2026 · Q3
Revenue	$19.5M–$20.5M	—
FY 2026 · Q4
Revenue	—	18.66M
EPS	—	-0.248
FY 2026 · Annual
Revenue	$60M–$70M	72.5M
EPS	—	-1.06
Capital expenditure	$40M–$50M	—
Operating expenses	$45M–$55Mnon-GAAP	—
FY 2027 · Annual
Revenue	—	92.08M
EPS	—	-0.673

What the Thesis Depends On

4 published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Capex between $40M and $50M in FY26	A supporting condition in Velo3D Inc's published investment case. The stated target is $40M to $50M capex in FY26.	Intact	Capex exceeds $60M in FY26	Capital expenditures: $3.518M FY2026-Q2; GAAP. Published target: $40M to $50M capex in FY26. Target period is not explicitly aligned with this observation. Source published Aug 11, 20263,518,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Maintain gross margin at or above 30% in FY26	The company has reaffirmed a gross margin above 30%.	Broken	Gross margin falls below 25% in FY26	Gross margin: 21.5% FY2026-Q2; GAAP. Published target: >= 30% gross margin in FY26. Target period is not explicitly aligned with this observation. Source published Aug 11, 202621.496322 percent · calculatedSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: b6cb14b1-8cb9-4078-8eab-be29ce6e9616. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Achieve positive EBITDA in second half of 2026	Management targets positive EBITDA in the second half of 2026.	Broken	EBITDA remains negative through end of 2026	Ebitda: $-10.349M FY2026-Q2; GAAP. Published target: EBITDA > 0 in H2 2026. Target period is not explicitly aligned with this observation. Source published Aug 11, 2026-10,349,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Achieve $60M to $70M revenue in FY26	A primary condition in Velo3D Inc's published investment case. The stated target is >= $60M revenue in FY26.	Intact	Annual revenue falls below $45M in FY26	Revenue: $20.664M FY2026-Q2; GAAP. Published target: >= $60M revenue in FY26. Target period is not explicitly aligned with this observation. Source published Aug 11, 202620,664,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: b6cb14b1-8cb9-4078-8eab-be29ce6e9616. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS: comparable history unavailable.

FY2027 revenueUnavailable

Unavailable → Unavailable · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	Unavailable	Unavailable	2 / 4
2026-07-25	Unavailable	Unavailable	1 / 4
2026-07-26	Unavailable	Unavailable	1 / 4
2026-07-27	Unavailable	Unavailable	1 / 4
2026-07-28	Unavailable	Unavailable	1 / 4
2026-07-29	Unavailable	Unavailable	2 / 4
2026-07-30	Unavailable	Unavailable	1 / 4
2026-07-31	Unavailable	Unavailable	2 / 4
2026-08-01	Unavailable	Unavailable	2 / 4
2026-08-02	Unavailable	Unavailable	2 / 4
2026-08-03	Unavailable	Unavailable	1 / 4
2026-08-04	Unavailable	Unavailable	1 / 4
2026-08-05	Unavailable	$89,675,400	2 / 5
2026-08-06	Unavailable	$89,675,400	2 / 5
2026-08-08	Unavailable	$89,675,400	2 / 5
2026-08-09	Unavailable	Unavailable	2 / 4
2026-08-10	Unavailable	Unavailable	2 / 4
2026-08-12	Unavailable	Unavailable	2 / 4
2026-08-13	Unavailable	Unavailable	2 / 4
2026-08-14	Unavailable	Unavailable	2 / 4
2026-08-15	Unavailable	Unavailable	2 / 4
2026-08-16	Unavailable	Unavailable	2 / 4
2026-08-17	Unavailable	Unavailable	2 / 4
2026-08-18	Unavailable	Unavailable	2 / 4
2026-08-19	Unavailable	Unavailable	2 / 4
2026-08-20	Unavailable	Unavailable	2 / 4
2026-08-21	Unavailable	Unavailable	2 / 4
2026-08-22	Unavailable	Unavailable	2 / 4
2026-08-23	Unavailable	Unavailable	2 / 4
2026-08-24	Unavailable	Unavailable	2 / 4
2026-08-25	Unavailable	Unavailable	2 / 4
2026-08-26	Unavailable	Unavailable	2 / 4
2026-08-27	Unavailable	Unavailable	2 / 4
2026-08-28	Unavailable	Unavailable	2 / 4
2026-08-29	Unavailable	$92,082,000	2 / 5
2026-08-30	Unavailable	$92,082,000	2 / 5
2026-08-31	Unavailable	$92,082,000	2 / 5
2026-09-01	Unavailable	$92,082,000	2 / 5
2026-09-02	Unavailable	$92,082,000	2 / 5
2026-09-03	Unavailable	$92,082,000	2 / 5
2026-09-04	Unavailable	$92,082,000	2 / 5
2026-09-05	Unavailable	$92,082,000	2 / 5
2026-09-06	Unavailable	$92,082,000	2 / 5
2026-09-07	Unavailable	$92,082,000	2 / 5
2026-09-08	Unavailable	$92,082,000	2 / 5
2026-09-09	Unavailable	$92,082,000	2 / 5
2026-09-10	Unavailable	$92,082,000	2 / 5
2026-09-11	Unavailable	$92,082,000	2 / 5
2026-09-12	Unavailable	$92,082,000	2 / 5
2026-09-13	Unavailable	$92,082,000	2 / 5
2026-09-14	Unavailable	$92,082,000	2 / 5
2026-09-15	Unavailable	$92,082,000	2 / 5
2026-09-16	Unavailable	$92,082,000	2 / 5
2026-09-17	Unavailable	$92,082,000	2 / 5
2026-09-18	Unavailable	$92,082,000	2 / 5
2026-09-19	Unavailable	$92,082,000	2 / 5
2026-09-20	Unavailable	$92,082,000	2 / 5
2026-09-21	Unavailable	$92,082,000	2 / 5
2026-09-22	Unavailable	$92,082,000	2 / 5
2026-09-23	Unavailable	$92,082,000	2 / 5
2026-09-24	Unavailable	$92,082,000	2 / 5
2026-09-25	Unavailable	Unavailable	2 / 4
2026-09-26	Unavailable	Unavailable	2 / 4
2026-09-27	Unavailable	Unavailable	2 / 4
2026-09-28	Unavailable	Unavailable	2 / 4
2026-09-29	Unavailable	Unavailable	2 / 4
2026-09-30	Unavailable	Unavailable	2 / 4
2026-10-01	Unavailable	Unavailable	2 / 4
2026-10-02	Unavailable	Unavailable	2 / 4
2026-10-03	Unavailable	Unavailable	2 / 4
2026-10-04	Unavailable	Unavailable	2 / 4
2026-10-05	Unavailable	Unavailable	2 / 4
2026-10-06	Unavailable	Unavailable	2 / 4
2026-10-07	Unavailable	Unavailable	2 / 4
2026-10-08	Unavailable	Unavailable	2 / 4
2026-10-09	Unavailable	Unavailable	2 / 4
2026-10-10	Unavailable	Unavailable	2 / 4
2026-10-11	Unavailable	Unavailable	2 / 4
2026-10-12	Unavailable	Unavailable	2 / 4
2026-10-13	Unavailable	Unavailable	2 / 4
2026-10-14	Unavailable	Unavailable	2 / 4
2026-10-15	Unavailable	Unavailable	2 / 4
2026-10-16	Unavailable	Unavailable	2 / 4
2026-10-17	Unavailable	Unavailable	2 / 4
2026-10-18	Unavailable	Unavailable	2 / 4
2026-10-19	Unavailable	Unavailable	2 / 4
2026-10-20	Unavailable	Unavailable	2 / 4
2026-10-21	Unavailable	Unavailable	2 / 4
2026-10-22	Unavailable	Unavailable	2 / 4
2026-10-23	Unavailable	Unavailable	2 / 4
2026-10-24	Unavailable	Unavailable	2 / 4

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-05-01	2	0	0
2026-06-01	3	0	0
2026-07-01	4	0	0
2026-08-01	5	0	0
2026-09-01	5	0	0
2026-10-01	4	0	0

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 4 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Sep 25–Oct 24 · 0 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Capex between $40M and $50M in FY26Capital expenditures: $3.518M
Maintain gross margin at or above 30% in FY26Published status: Broken
Achieve positive EBITDA in second half of 2026Published status: Broken
Achieve $60M to $70M revenue in FY26Revenue: $20.664M

Next proof point

Nov 9, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

5.0%Typical daily move · historical

Downside history

-78.8%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Velo3D Inc outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

VELO is a high-risk, loss-making growth business, not yet a proven durable compounder. Its long-term thesis is in a watch state: revenue progress is visible, but recent performance and management execution remain weak or uncertain.

What's priced into Velo3D Inc

The valuation signal is described as justified, with expectations broadly aligned, but the valuation measure has fallen from 41.4 to 23.9 and the signal has shifted to cautious. The evidence does not give a clear peer valuation label, so whether the shares are cheap, fair, or expensive versus peers is uncertain.

What the fundamentals likely do

Near term, earnings-miss risk is elevated, and the October 15 miss adds to concern about weak recent performance. Revenue rose from $13.816 million in the first quarter to preliminary third-quarter revenue of $19.5 million to $20.5 million, and management raised its 2026 revenue guidance; however, the first-quarter adjusted EBITDA loss and unverified progress on RPS production and capacity leave execution unproven.

What Velo3D Inc hinges on

The key test is whether VELO can deliver its raised revenue guidance, expand RPS production, and reach its stated goal of positive EBITDA in the second half of 2026. Further guidance cuts would be a meaningful negative; easier interest rates or stronger results and guidance from sector bellwethers could support the sector backdrop, but would not resolve VELO’s company-specific execution risks.